proposed change to drug approval process in canada to cut costs?

1
PharmacoEconomics & Outcomes News 328 - 1 Sep 2001 In an effort to curtail soaring prescription drug expenditure in Canada, federal Health Minister Allan Rock has proposed making cost effectiveness a criterion determining whether a new drug is reimbursed by government drug plans, reports the Lancet. Many new drugs, he says, are far more costly than their predecessors and yet only marginally more effective. In the 15 years to date, spending on prescription drugs in Canada has risen nearly 350%, according to the Canadian Institute of Health Information. The proposal has not been well received by pharmaceutical manufacturers; they say that such a move will stifle innovation. Rock hopes that a new approach to drug approvals will be adopted in 2002. Kondro W. Canadian drive to curb drug expenditure. Lancet 358: 648, 25 Aug 2001 800876027 1 PharmacoEconomics & Outcomes News 1 Sep 2001 No. 328 1173-5503/10/0328-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: truongthien

Post on 16-Mar-2017

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Proposed change to drug approval process in Canada to cut costs?

PharmacoEconomics & Outcomes News 328 - 1 Sep 2001

■ In an effort to curtail soaring prescription drugexpenditure in Canada, federal Health Minister AllanRock has proposed making cost effectiveness acriterion determining whether a new drug isreimbursed by government drug plans, reports theLancet. Many new drugs, he says, are far more costlythan their predecessors and yet only marginally moreeffective. In the 15 years to date, spending onprescription drugs in Canada has risen nearly 350%,according to the Canadian Institute of HealthInformation. The proposal has not been well receivedby pharmaceutical manufacturers; they say that such amove will stifle innovation. Rock hopes that a newapproach to drug approvals will be adopted in 2002.Kondro W. Canadian drive to curb drug expenditure. Lancet 358: 648, 25 Aug2001 800876027

1

PharmacoEconomics & Outcomes News 1 Sep 2001 No. 3281173-5503/10/0328-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved